Forte Research Systems, an industry-leading developer of specialized clinical research management software, today announced the launch of Nimblify, Inc., a subsidiary. Nimblify will operate independently of Forte, and the company will focus solely on creating efficiencies across all stakeholders within the clinical research industry.
“In our time dedicated to developing CTMS and EDC systems, we’ve met with people from many different corners of the industry, and we’ve heard about and witnessed the gaps and inefficiencies that exist in clinical research today,” said Srini Kalluri, Founder, President, CEO, and Chief Customer Officer of Forte. “We are excited about the opportunities for our dedicated team at Nimblify, as they work to solve these inefficiencies in innovative and thoughtful ways.”
Nimblify will launch its first initiative this fall. Overall, the company’s development efforts will center upon creating solutions that span the entire clinical research industry. These solutions will allow for multi-stakeholder interactions among sponsors, CROs, research sites, and research study participants.
“It is clear the clinical research industry is ripe for change,” Kalluri added. “People are ready to start working together, and we are looking forward to leveraging the expertise that we have developed over the past 15 years to spur game-changing innovation and inventiveness in the ecosystem of clinical research.”
Forte secured a major growth investment from Primus Capital (Primus) in May this year, and the launching of Nimblify is the first new growth initiative to occur as a result of this funding.
About Forte Research Systems, Inc.
Forte Research Systems, Inc. has been developing specialized software for clinical research since 2000. The software product family includes OnCore® Enterprise Research, Allegro® CTMS, and Overture® EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble® Community, the Allegro Community, and Research Resonance® Network, a technology-enabled community of sites pursuing data-driven excellence in clinical research operations.
About Nimblify, Inc.
Nimblify, Inc., a subsidiary of Forte Research Systems, is a clinical trials technology company dedicated to creating industry-wide efficiencies by connecting stakeholders in clinical research. The company’s first offering is a participant-centered payment system that enables research sites to easily and securely compensate study volunteers immediately after each visit occurs. Founded in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit Nimblify.com.